Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|April 1, 1996
Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitisM G Hartley, M J Hudson, E T Swarbrick, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.
Lancet (London, England)|July 7, 1979
Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel diseaseE T Swarbrick, J G Kingham, H L Price, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 22, 2009
Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centreP Ellul, E Fogden, C L Simpson, et al.
Journal of Medical Microbiology|February 1, 1992
The rectal mucosa-associated microflora in patients with ulcerative colitisM G Hartley, M J Hudson, E T Swarbrick, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1992
Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 monthsJ R Green, C H Swan, A Rowlinson, et al.
BMJ (Clinical Research Ed.)|July 4, 1992
Randomised controlled trial of azathioprine withdrawal in ulcerative colitisA B Hawthorne, R F Logan, C J Hawkey, et al.
Lancet (London, England)|March 20, 1982
Colonoscopic diagnosis of minimal change colitis in patients with a normal sigmoidoscopy and normal air-contrast barium enemaP R Elliott, C B Williams, J E Lennard-Jones, et al.
Pageof 4